From theheart.org on Medscape

Coverage from the

American Heart Association (AHA) Scientific Sessions 2017

November 11 - 15, 2017; Anaheim, California

November 11 - 15, 2017 Anaheim, California

Booth # 2535

AHA Readmission-Reduction Program Linked to Higher HF Mortality The findings are at odds with a recent study that came to the opposite conclusion and have roused a raucous debate over unintended consequences of the CMS Hospital Readmissions Reduction Program.
Medscape Medical News, November 21, 2017
AHA New ACC/AHA Hypertension Guidelines Make 130 the New 140 New guidelines endorsed by 11 organizations lower the threshold for stage 1 hypertension to include adults with systolic pressure from 130 to 139 mm Hg or 80 to 89 mm Hg diastolic.
Medscape Medical News, November 13, 2017
AHA TRICS-3 Disputes 'Liberal' RBC Transfusions at Cardiac Surgery "Blood is expensive and blood is toxic," points out an observer of the largest-yet trial looking at the issue: good reasons to avoid transfusions in cardiac surgery only to keep hemoglobin levels high.
Medscape Medical News, November 12, 2017

Meeting Highlights At A Glance

Top News From AHA 2017: Slideshow Highlights include new hypertension guidelines that change the very definition of hypertension, plus a study disputing liberal transfusions at cardiac surgery.

Conference News

AHA STEMI Quality-Improvement Program in Kerala, India 'a Success'
Medscape Medical News, December 5, 2017
AHA Adding Rivaroxaban to Aspirin Cuts Costs in Secondary Prevention
Medscape Medical News, December 5, 2017
AHA PRECISION: Aspirin Undermines Safety Profile of Celecoxib
Medscape Medical News, December 4, 2017
AHA For Earlier PCI in STEMI, Sync Prehospital-Hospital Care
Medscape Medical News, December 1, 2017
AHA Empagliflozin Particularly Effective in 'Vulnerable' Diabetes Subgroup
Medscape Medical News, November 28, 2017
AHA CANVAS: No Difference in Canagliflozin Effects by Prior CV Status
Medscape Medical News, November 27, 2017
AHA Device Therapy for Preserved-EF HF? Shunt Safely Eases LA Pressures
Medscape Medical News, November 24, 2017
AHA Gobbling Food May Boost Metabolic Risk
Medscape Medical News, November 22, 2017
AHA Cell Therapy Shows 'Hope' for Duchenne Cardiomyopathy
Medscape Medical News, November 22, 2017
AHA Treadmill Training, Not Cell Therapy, Aids Walking in PAD: PROPEL
Medscape Medical News, November 22, 2017
AHA FOURIER: Aim PCSK9 Inhibitors at Highest of High-Risk Patients?
Medscape Medical News, November 21, 2017
AHA Readmission-Reduction Program Linked to Higher HF Mortality
Medscape Medical News, November 21, 2017
AHA Telepharmacy Program Improves Adherence, Not CV Outcomes
Medscape Medical News, November 20, 2017
AHA New RE-DUAL PCI Data: Dabigatran Dual Therapy Benefit Consistent
Medscape Medical News, November 17, 2017
AHA Botox Injections to the Heart May Tamp Down Postop AF
Medscape Medical News, November 15, 2017
AHA POISE-2: PCI Patients May Benefit From Perioperative Aspirin
Medscape Medical News, November 15, 2017

AHA Diabetes Linked to All-Cause and Sudden Death in the Young
Medscape Medical News, November 15, 2017
AHA PRAGUE-18 Hints at Risk-Based Personalized DAPT After STEMI-PCI Discharge
Medscape Medical News, November 15, 2017
AHA High-Dose Statins Decrease CV Events in Asian CAD Patients
Medscape Medical News, November 14, 2017
AHA New ACC/AHA Hypertension Guidelines Make 130 the New 140
Medscape Medical News, November 13, 2017
AHA Sex Rarely Causes Cardiac Arrest, Even in Cardiac Patients
Medscape Medical News, November 13, 2017
AHA Bariatric Surgery Can Lead to HTN 'Remission' in Obese: GATEWAY
Medscape Medical News, November 13, 2017
AHA SPRINT: Attended, Unattended BP Measures Do Not Affect Outcomes
Medscape Medical News, November 13, 2017
AHA Secondary CANTOS Analysis IDs Canakinumab Responders
Medscape Medical News, November 13, 2017
AHA DACAB: Ticagrelor Plus Aspirin Improves CABG Graft Patency
Medscape Medical News, November 12, 2017
AHA Direct Oral Anticoagulants Can Continue During Cardiac-Device Surgery
Medscape Medical News, November 12, 2017
AHA No Benefit From Bicarbonate, Acetylcysteine Postangiography
Medscape Medical News, November 12, 2017
AHA TRICS-3 Disputes 'Liberal' RBC Transfusions at Cardiac Surgery
Medscape Medical News, November 12, 2017
AHA New Program Helps Sixth Graders Learn Hands-Only CPR
Medscape Medical News, November 12, 2017
AHA Bystander CPR in Public More Likely for Men Than for Women
Medscape Medical News, November 11, 2017
AHA New Hypertension Guidelines to Debut at AHA Scientific Sessions
Medscape Medical News, November 8, 2017

Popular News from AHA 2016

PRECISION: Celecoxib Similar to Ibuprofen, Naproxen for CV Risk Celecoxib hit its noninferiority CV mark against ibuprofen and naproxen in arthritis patients at increased CVD risk, but not all are convinced.
Medscape Medical News, Nov 13, 2016
Statin Did Not Harm, BP Therapy Did Not Help Cognition: HOPE-3 "This gives me more evidence to tell my patients, when I'm discussing the use of statins, that they need not be concerned that these will impair their ability to think," says one expert.
Medscape Medical News, Nov 13, 2016 6:15:39 PM
Marijuana Use Can Double Risk of Takotsubo Cardiomyopathy It reflects correlation, not causation, but male active marijuana users who present with MI-like symptoms may actually have stress cardiomyopathy, an observational study suggests.
Medscape Medical News, Nov 22, 2016

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Artificial Intelligence in Cardiology: Friend or Foe?
John M. Mandrola, MD; Mintu Turakhia, MD, MAS
What Cardiologists Need to Know About New Diabetes Drugs
Interviewer: Michelle L. O'Donoghue, MD, MPH; Interviewee: Darren K. McGuire, MD, MHSc
Informed Patients May Choose Less Aggressive Care
John M. Mandrola, MD; Larry A. Allen, MD, MHS
What COMPASS and RE-DUAL Mean for Aspirin and Triple Therapy
Michelle L. O'Donoghue, MD, MPH; David J. Cohen, MD
Are Heart Failure Outcomes Measures Hurting Patients?
John M. Mandrola, MD;
Larry A. Allen, MD, MHS
PCSK9 Inhibitors: Is There a Palatable Price Point?
Michelle L. O'Donoghue, MD, MPH; Jennifer G. Robinson, MD, MPH; David J. Cohen, MD, MSc
An Enthusiastic Embrace of the New Hypertension Guidelines
Clyde W. Yancy, MD, MSc;
Patrick T. O'Gara, MD
New Goals and Guidelines for Hypertension
Melissa Walton-Shirley, MD;
Paul K. Whelton, MD, MSc
Mandrola Previews AHA 2017
John Mandrola, MD

Bloggers From the Floor

Better Patient Decisions: A Destination Within Reach A study showing that a comprehensive decision aid could help patients make treatment choices in line with their values is Dr Mandrola’s favorite trial of AHA 2017.
What if Quality Measures Increased Mortality? Dr Mandrola reports on a provocative study showing that reducing readmissions for heart failure associates with higher mortality.
Ushering in a New Era of Disease Prediction Dr Mandrola attended a young investigators award session and reports on the future of risk prediction--which means knowing our DNA.
Gastric Bypass for the Less Obese? Dr Walton-Shirley is reluctant to send obese patients for gastric bypass surgery, but concedes that the GATEWAY study findings are impressive.
Trials We Did, Trials We Should Do Dr Walton-Shirley reflects on some major studies presented at AHA 2017 and offers a further way to approach each one.
Mentoring and Paying It Forward for Women in Cardiology Almost 10 years ago, a high school student asked to shadow Dr Walton Shirley. Now Katrina Bidwell is presenting at the American Heart Association and about to start her cardiology fellowship

Previous Coverage